Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Osteoarthritis
•
Orthopedics
•
Sports Medicine
How do you counsel patients with autoimmune disease who are considering platelet-rich plasma injections for a musculoskeletal condition unrelated to their autoimmune disease?
Related Questions
What is your approach to work up for patients referred for early onset osteoarthritis?
Do you avoid hyaluronic acid injections in patients with chondrocalcinosis on imaging?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
Do you restrict topical diclofenac use in your patients with chronic kidney disease?
Do you prescribe additional exercise for patients who perform manual labor?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
Do you recommend sending an autoimmune work up for patients with recurrent nephrolithiasis and 24 hour urine chemistries consistent with distal renal tubular acidosis?
What do you include in your differential for patients with recurrent large volume, non-inflammatory joint effusions?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
